ANNOUNCEMENT 18 Jan 2013

The Brazilian government-funded Company of Innovation and Research (FINEP) approved a loan of BRL 70 million to União Química Farmacêutica Nacional S.A. 

NUMBER OF INTERVENTIONS

1

  • 1 harmful
  • 0 neutral
  • 0 liberalising

SOURCE

Brazilian Company of Innovation and Research. Empresa Brasileira de Inovaçao e Pesquisa. Projetos contratados e valores liberados. Retrieved on 02/05/2018. Available at: http://finep.gov.br/acesso-a-informacao-externo/transparencia/projetos-contratados-e-valores-liberados

Brazilian Company of Innovation and Research. Empresa Brasileira de Inovaçao e Pesquisa. Financiamento Reembolsável. Available at: http://finep.gov.br/component/content/article/120-apoio-e-financiamento/tipos-de-apoio/financiamento-reembolsavel/42-financiamento-reembolsavel

Inception date: 18 Jan 2013 | Removal date: 18 Jan 2017

State loan

On 18 January 2013, the Brazilian Company of Innovation and Research (FINEP) announced the approval of a loan of BRL 70 million (over USD 34.2 million) allocated to União Química Farmacêutica Nacional S.A., a Brazilian-based pharmaceutical company that sells pharmaceutical, OTC, and generic medicinal products. These resources will finance the innovation program of the company.

The repayment deadline for the credit has been set to 18 January 2017.


FINEP lending
The resources enclosed on the programs managed by FINEP are limited to Brazilian companies and seek to boost the national and international competitiveness of these businesses.

The interest rates set on the credit lines are composed of the long-term interest rate (TJLP) plus a supplement ranging between 1.5% and 7%, depending on the credit line and the repayment period.

AFFECTED SECTORS

 

AFFECTED PRODUCTS

 
N/A